Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
November 2025
The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyCookie settingsWe may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
Privacy policy
Nova biomedical
, /in Advertenties /by panglobalThe Most Clinically Advanced Critical Care Test Menu Now Includes Creat•eGFR•BUN•ePV•iMg•MCHC
Pittcon
, /in Advertenties /by panglobalUNLOCKING INNOVATION TOGETHER: ADVANCING POINT OF CARE TESTING
The Intelligent Analyzer GEM
, /in Advertenties /by panglobalGEM Premier 5000 blood gas testing system provides automated quality assurance with every whole-blood* sample. Now with next-generation Intelligent Quality Management (iQM2), featuring IntraSpect™ technology, potential errors are detected not only before and after, but also during sample analysis, along with real-time correction and documentation.
Diagnosis and management of subarachnoid hemorrhage
, /in Featured Articles, Microscopy & Imaging /by panglobalIf a patient has a suspected subarachnoid brain hemorrhage (SAH), time is of the essence. CLI chatted to Dr Suneesh Thilak (New Cross Hospital, Wolverhampton, UK) to find out about the role that imaging plays in diagnosis, securement and subsequent patient management of SAH.
Technological advances allow use of mid-infrared spectroscopy for therapeutic drug monitoring
, /in Featured Articles, Therapeutic Drug Monitoring /by panglobalTherapeutic drug monitoring is used for a number of reasons. The usual techniques include immunoassay and mass spectrometry, both of which have limitations. CLI chatted to Dr Pin Dong (University of York, York, UK) to discuss the potential for Fourier transform infrared spectroscopy to bridge the gap and provide high specificity measurements with a fast […]
Revvity’s new automated free testosterone assay receives FDA clearance
, /in Product News /by panglobalRevvity Inc has announced FDA 510(k) clearance for EUROIMMUN’s automated chemilumin-escence immunoassay (ChLIA) for direct quantitative measurement of free testosterone. The assay, which runs on the company’s iSYS and i10 platforms, represents the first FDA-cleared automated direct measurement method for free testosterone in human serum or plasma.
Sapio Sciences expands laboratory informatics capabilities
, /in Product News /by panglobalLaboratory software provider Sapio Sciences has announced significant updates to its informatics platform, enhancing functionality across chemistry, immunogenicity, GMP workflows and molecular biology. Release 24.12 introduces automated validation tools and refined chemistry representation capabilities, aimed at improving laboratory efficiency and data management.
Thermo Fisher unveils DNA/RNA extraction kit for haematological cancer research
, /in Product News /by panglobalA new sequential DNA/RNA isolation kit has been launched by Thermo Fisher Scientific, designed to streamline genomic analysis workflows in haematological cancer research. The MagMAX Sequential DNA/RNA kit enables concurrent extraction of DNA and RNA from a single sample, potentially accelerating research into blood-based malignancies.
Serum Amyloid A (SAA) nephelometric and turbidimetric assays
, /in Product News /by panglobalTRIMERO Diagnostics offers assays for testing Serum Amyloid A (SAA) on Beckman Coulter’s IMMAGE® Immunochemical Systems and Clinical Chemistry Analyzers.
Johnson & Johnson acquires lumateperone developer in £14.6bn deal
, /in E-News /by panglobalJohnson & Johnson (J&J) has announced the acquisition of Intra-Cellular Therapies for $14.6 billion, marking a significant expansion of its neuroscience portfolio. The deal centres on CAPLYTA (lumateperone), a novel antipsychotic with a distinctive pharmacological profile characterised by high serotonin 5-HT2A receptor occupancy combined with lower dopamine D2 receptor binding at therapeutic doses.